Abstract

Sericin is a component of cocoons. Studies have shown that sericin improves metabolic disease in animal model. However, it is not yet known whether sericin is effective in the treatment of non-alcoholic steatohepatitis. Twenty C57BL/6N mice were divided into control and sericin treated group. High fat diet was fed to mice for 10 weeks. From 11^th to 21^st week sericin and distilled water were administered assigned groups via oral gavage. Body weight and liver to body weight ratio was assessed. AST, ALT, triglyceride, cholesterol and blood glucose levels were measured. qRT-PCR, Electro-microscopy, and Free fatty acid induced lipotoxicity assay were performed. Mitochondrial membrane potential was checked. As a result, there were no differences in body weight and diet intake in two groups. However, liver weight and liver/body weight ratio were significantly decreased in sericin group than in control group. Both the degree of hepatic steatosis and inflammation were lower in sericin group than the control group. NAFLD activity score were also decreased in treatment group. Serum ALT, AST, and triglyceride levels as well as area under receiver operating characteristics of oral glucose tolerance test were significantly decreased in sericin group. Hepatic mRNA expressions of TNF-α, MCP-1, and IL-6 mRNA were decreased in sericin group. Electron microscopy findings showed restoration of abnormal mitochondria with sericin treatment. Lipotoxicity induced HepG2 cell death was significantly attenuated in palmitic acid and sericin co-treated cells. Sericin also prevented palmitic acid induced mitochondrial depolarization. In conclusion, Sericin peptide treatment attenuated non-alcoholic steatohepatitis via mitochondrial function modulation.

Keywords: Sericin; Nonalcoholic steatohepatitis; Mitochondria

References

1. Li J., et al. "Prevalence, Incidence, and Outcome of Non-Alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-Analysis”. Lancet Gastroenterology and Hepatology 4.5 (2019): 389-398.
2. Lim CY., et al. "Effects of Carnitine on Peripheral Blood Mitochondrial DNA Copy Number and Liver Function in Non-Alcoholic Fatty Liver Disease”. Korean Journal of Gastroenterology 55.6 (2010): 384-9.
3. Oh H., et al. "Non-Alcoholic Fatty Liver Diseases: Update on the Challenge of Diagnosis and Treatment”. Clinical and Molecular Hepatology 22.3 (2016): 327-335.
4. Simoes ICM., et al. "Mitochondria in Non-Alcoholic Fatty Liver Disease”. The International Journal of Biochemistry and Cell Biology 95 (2018): 93-99.
5. Nassir F and JA Ibdah. "Role of Mitochondria in Nonalcoholic Fatty Liver Disease”. International Journal of Molecular Sciences 15.5 (2014): 8713-8742.
6. Kundu Subhas C., et al. "Natural Protective Glue Protein, Sericin Bioengineered by Silkworms: Potential for Biomedical and Biotechnological Applications”. JPPS Progress in Polymer Science 33.10 (2008): 998-1012.
7. Padol Amol., et al. "Natural Biomaterial Silk and Silk Proteins: Applications in Tissue Repair”. International Journal of Materials and Biomaterials Applications 2 (2012): 19-24.
8. Ampawong S., et al. “Sericin Ameliorated Dysmorphic Mitochondria in High-Cholesterol Diet/Streptozotocin Rat by Antioxidative Property”. Experimental Biology and Medicine (Maywood) 242.4 (2017): 411-421.
9. Kleiner DE., et al. "Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease”. Hepatology 41.6 (2005): 1313-1321.
10. Okazaki Y., et al. "Consumption of Sericin Reduces Serum Lipids, Ameliorates Glucose Tolerance and Elevates Serum Adiponectin in Rats Fed a High-Fat Diet”. Bioscience, Biotechnology, and Biochemistry 74.8 (2010): 1534-1538.
11. Lapphanichayakool P., et al. “Hypocholesterolemic Effect of Sericin-Derived Oligopeptides in High-Cholesterol Fed Rats”. Journal of Natural Medicines 71.1 (2017): 208-215.
12. Deori M., et al. “Antioxidant Effect of Sericin in Brain and Peripheral Tissues of Oxidative Stress Induced Hypercholesterolemic Rats”. Frontiers in Pharmacology 7 (2016): 319.
13. Jun DW., et al. "Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity by Carnitine Via Reversal of Mitochondrial Dysfunction”. Liver International 31.9 (2011): 1315-24.
14. Gonzalez-Franquesa A and ME Patti. "Insulin Resistance and Mitochondrial Dysfunction”. Advances in Experimental Medicine and Biology 982 (2017): 465-520.

Citation

Citation: Dae Won Jun.,et al. “Sericin Peptide Attenuates Non-Alcoholic Steatohepatitis Via Mitochondrial Function Modulation". Acta Scientific Nutritional Health 4.9 (2020): 42-52.

Copyright

Copyright: © 2020 Dae Won Jun.,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.